Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.

Generate Key Takeaways What are the most common COVID-19 symptoms doctors are seeing in025? Read on to find out what to look ...

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

Researchers examine the effectiveness of a novel taste-based sensor for the early detection of influenza infection.

As flu season arrives, a new highly infectious COVID-19 variant, Stratus (XFG), is driving a surge in US cases, first ...

“Given India’s success in curbing international outbreaks such as Zika and the Nipah virus infections, Asian countries have ...

Have you ever experienced the sudden onset of a cold, fever, cough, and shortness of breath? In most cases, people tend to self-diagnose these symptoms as the flu. Yet unbeknownst to many, these signs ...

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...

Covid-19 has infected more than 235M people and killed over 4.8M globally. Here are the virus-related developments for October 4: ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

German scientists have designed a new molecular sensor to release a thyme flavor when it encounters the flu virus.

GARDENA, CALIFORNIA / ACCESS Newswire / September 25, 2025 / OPEN Healthcare proudly announces the grand opening of its new state-of-the-art 23,000-square-foot clinical laboratory in Gardena, ...